Kivexa【C】

Anti-infective Agents : Antiretroviral Agents
OKIVE1 “Kivexa FC tablet

Each tablet contains abacavir sulfate 600 mg, lamivudine 300 mg

適應症:用於治療成人及大於十二歲青少年的抗反轉錄病毒合併療法,以治療人類免疫不全病毒(HIV)之感染。

Usual dose:

HIV infection: 1 tab PO qd.

Dose adjustment:

Renal impairment: CrCl < 50 ml/min, not recommended.

Contradiction: hepatic impairment.

Adverse effect:

Common: abdominal pain, diarrhea, gastritis, headache, fatigue

Serious: lactic acidosis, hepatomegaly (severe, with steatosis), immune hypersensitivity reaction (2.3-9%, abacavir).

Related Entries

(Visited 39 times, 1 visits today)